UK markets close in 2 hours 35 minutes

Madrigal Pharmaceuticals, Inc. (MDGL)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
201.07+7.74 (+4.00%)
At close: 04:00PM EDT
202.50 +1.43 (+0.71%)
Pre-market: 08:46AM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts13131515
Avg. Estimate-6.28-6.61-23.57-14.69
Low estimate-7.34-8.33-32.21-27.28
High estimate-4.86-5.45-13.67-3.06
Year ago EPS-4.23-4.69-19.99-23.57
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts10121212
Avg. EstimateN/A4.3M89.05M368.05M
Low estimateN/AN/A61.11M201.78M
High estimateN/A15M112.4M509.22M
Year ago salesN/AN/AN/A89.05M
Sales growth (year/est)N/AN/AN/A313.30%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-4.94-4.58-4.92-5.28
Actual EPS-4.23-4.69-5.34-5.68
Difference0.71-0.11-0.42-0.4
Surprise %14.40%-2.40%-8.50%-7.60%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-6.28-6.61-23.57-14.69
7 days ago-6.28-6.61-23.57-14.69
30 days ago-6.3-6.62-23.48-14.46
60 days ago-5.49-5.76-20.91-7.93
90 days ago-5.02-5.29-16.4-3.18
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesMDGLIndustrySector(s)S&P 500
Current qtr.-48.50%N/AN/AN/A
Next qtr.-40.90%N/AN/AN/A
Current year-17.90%N/AN/AN/A
Next year37.70%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A